Osaka University describes new radiolabeled tyrosine derivatives targeting LAT1
April 17, 2024
Osaka University has identified radiolabeled tyrosine derivatives targeting large neutral amino acids transporter small subunit 1 (SLC7A5; LAT1) reported to be useful for the treatment of cancer.